Dengue Vaccines Market Revenue 2024 to 2034
Dengue Vaccines Market Revenue 2024 to 2034
The Dengue Vaccines Market is set to grow from USD 28.76 Bn in 2024 to USD 92.47 Bn by 2034 at 12.39% CAGR, fueled by rising dengue incidence, climate-driven outbreaks, and expanded vaccination programs.
Report ID: 10410
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 28.76 Bn
Forecast Year,
USD 92.47 Bn
CAGR, 2025 -
12.39%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Dengue Vaccines Market Size Analysis
Dengue Vaccines Market Size By Therapy & Class 2024 to 2034 (USD )
| Therapy & Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 9.20 | 10.35 | 11.60 | 13.03 | 14.61 | 16.40 | 18.41 | 20.62 | 22.98 | 25.79 | 29.01 |
| Biologics | 9.78 | 11.00 | 12.38 | 13.84 | 15.53 | 17.35 | 19.44 | 21.94 | 24.80 | 28.04 | 31.53 |
| Advanced Therapies | 5.18 | 5.80 | 6.54 | 7.36 | 8.32 | 9.43 | 10.64 | 11.98 | 13.43 | 15.03 | 16.81 |
| Others | 4.60 | 5.18 | 5.81 | 6.60 | 7.43 | 8.39 | 9.47 | 10.59 | 12.00 | 13.41 | 15.13 |
Dengue Vaccines Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 10.35 | 11.69 | 13.12 | 14.75 | 16.55 | 18.64 | 21.00 | 23.63 | 26.49 | 29.61 | 33.37 |
| Cardio-Metabolic | 5.18 | 5.79 | 6.49 | 7.32 | 8.23 | 9.21 | 10.29 | 11.54 | 12.89 | 14.63 | 16.48 |
| Infectious | 4.60 | 5.18 | 5.87 | 6.57 | 7.40 | 8.33 | 9.38 | 10.43 | 11.84 | 13.33 | 14.99 |
| CNS | 4.03 | 4.52 | 5.08 | 5.67 | 6.31 | 7.06 | 7.91 | 8.93 | 9.98 | 11.21 | 12.60 |
| Others | 4.60 | 5.15 | 5.78 | 6.51 | 7.40 | 8.33 | 9.37 | 10.60 | 12.01 | 13.50 | 15.03 |
Dengue Vaccines Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 12.65 | 14.20 | 15.93 | 17.91 | 20.15 | 22.59 | 25.32 | 28.28 | 31.80 | 35.82 | 40.24 |
| Retail Pharmacy | 10.35 | 11.66 | 13.09 | 14.67 | 16.50 | 18.60 | 20.98 | 23.70 | 26.55 | 29.73 | 33.51 |
| Online/Other | 5.75 | 6.46 | 7.31 | 8.24 | 9.24 | 10.38 | 11.66 | 13.16 | 14.86 | 16.73 | 18.72 |
Dengue Vaccines Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 11.50 | 12.95 | 14.54 | 16.33 | 18.37 | 20.59 | 23.28 | 26.38 | 29.63 | 33.35 | 37.55 |
| Europe | 8.05 | 9.01 | 10.11 | 11.33 | 12.77 | 14.26 | 16.03 | 17.94 | 20.11 | 22.64 | 25.48 |
| Asia Pacific | 6.90 | 7.78 | 8.76 | 9.88 | 11.04 | 12.50 | 13.92 | 15.51 | 17.51 | 19.58 | 21.94 |
| Latin America | 1.15 | 1.29 | 1.47 | 1.65 | 1.86 | 2.11 | 2.37 | 2.66 | 2.97 | 3.37 | 3.76 |
| Middle East & Africa | 1.15 | 1.29 | 1.45 | 1.63 | 1.85 | 2.10 | 2.36 | 2.65 | 2.98 | 3.34 | 3.74 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
